US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: Healthcare Innovator with 61% Potential Upside

Insulet Corporation (NASDAQ: PODD), a leading player in the medical devices sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 26.66% Upside Awaits Investors

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector’s drug manufacturing niche, presents a compelling opportunity for investors seeking exposure to the over-the-counter..

Humana Inc. (HUM) Stock Analysis: Exploring a 28% Potential Upside Amidst Strong Revenue Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, presents an intriguing opportunity for investors, highlighted by a potential upside of 28.25% according..

Elanco Animal Health (ELAN) Stock Analysis: A 25% Upside in the Dynamic Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a formidable player in the healthcare sector, particularly within the niche of drug manufacturing for both specialty and..

BioNTech SE (BNTX) Stock Analysis: Unpacking the 42.60% Potential Upside and Market Dynamics

BioNTech SE (BNTX), a prominent player in the biotechnology sector, has recently captured investor attention with a notable potential upside of 42.60%, as indicated by its..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Upside Potential with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, offers an intriguing opportunity for investors looking for high growth potential in the healthcare..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Innovator with Nearly 49% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector’s diagnostics and research industry, is captivating investor attention with its expansive growth potential, underscored by..

Corcept Therapeutics (CORT) Stock Analysis: Exploring the 103% Potential Upside in Biotech Innovation

Corcept Therapeutics Incorporated (NASDAQ: CORT) is drawing attention from investors with its robust performance metrics and a striking potential upside of 103.42%. As a key player..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with a 14% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) continues to capture investor attention with its robust portfolio of diagnostic and therapeutic products aimed at enhancing the detection and treatment..

GE HealthCare Technologies Inc. (GEHC): Analyst Consensus Points to Significant 31.48% Upside Potential

GE HealthCare Technologies Inc. (GEHC), a key player in the healthcare sector, stands at the forefront of the medical devices industry, drawing investor attention with its..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech Play with 32.74% Potential Upside

For investors with an eye on the biotechnology sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity. With a market capitalization of $7.51 billion, this..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem with 69% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA), a burgeoning player in the biotech sector, has caught the attention of investors with its promising growth trajectory and significant upside..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 28.69% Potential Upside in the Innovative Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the medical devices industry, is captivating investor interest with its cutting-edge solutions in organ transplant therapy. With..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 171.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a dynamic player in the biotechnology sector, is catching the eye of investors with an impressive potential upside of 171.90%. As..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 23.29% Upside Potential in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector specializing in medical devices, is drawing significant attention from investors with its promising upside potential...

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 38.93% Potential Upside

Glaukos Corporation (NYSE: GKOS) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. Based in Aliso Viejo, California, this..

Medtronic plc (MDT) Stock Analysis: Navigating a 27.82% Potential Upside

For individual investors with an eye on the healthcare sector, Medtronic plc (NYSE: MDT) presents a compelling opportunity amidst the dynamic medical devices industry. Headquartered in..

Royalty Pharma plc (RPRX) Stock Analysis: A Robust Biopharma Royalty Player with a Potential 12.94% Upside

Royalty Pharma plc (NASDAQ: RPRX) is a compelling player in the biopharmaceutical industry, strategically positioned as a major buyer of biopharmaceutical royalties and a financier of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds